Articles

Patient-centricity has become an important focus for drug developers and an essential element of clinical studies aimed at showing that a new therapy addresses real patient needs. How companies define patient-centric trials sometimes differ. But to patients themselves, it typically...

A method of testing drugs thatprompt the immune system to attack and destroy cancer cells has been developed which can speed up drug discovering andreducethe unnecessary use of mice in drug screening programmes. Certain cancer drugs help the body’s immune...

Orphan genetic diseases have become an increasingly popular area for drug development through a variety of novel mechanistictherapeutic approaches. The development of a means to restore missing proteins to diseased cells consistently and efficiently remains a prominent goal in molecular...

Automation in its broadest sense has expanded from its original industrial manufacturing base to laboratories and businesses. The application of robotics and automation has been successfully achieved in a wide range of industries dealing with well...

The deadlines for serialisation compliance in the EU and the U.S. are drawing closer. For many pharmaceutical companies, the journey towards implementing a full serialisation solution is well underway, but for others the complexity of the task means that...

The market for organs-on-chips (OOCs), the cell culture chips that imitate the activities, mechanisms and responses of organs, will be worth $284 millionby 2021, according to research from The Business Research Company in its report Organ-On-Chip (OOC) Global Market...

A look at how pharmaceutical manufacturers can benefit from the use of dynamic checkweighing technology to comply with international standards, increase process safety, productivity and process control. The need for pharmaceutical manufacturers to rely on technological advancements has never been greater....